Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer’s disease
Fiona E McAlpine, Malú G TanseyAbstract: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that affects nearly one in two individuals over 90 years of age. Its neuropathological hallmarks are accumulation of extraneuronal plaques of amyloid-beta (A&...
Guardado en:
Autores principales: | Fiona E McAlpine, Malú G Tansey |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dcf27232b0da4b88bbc89cfb1d62d524 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting neuroinflammation in Alzheimer’s disease
por: Bronzuoli MR, et al.
Publicado: (2016) -
No evidence for activation of TH1 or TH17 pathways in unstimulated peripheral blood mononuclear cells from children with β-cell autoimmunity or T1D
por: Jenny Walldén, et al.
Publicado: (2008) -
Inflammation-related cytokine gene polymorphisms in Behçet’s disease
por: Al-Okaily F, et al.
Publicado: (2015) -
Knockout of the c-Jun N-terminal Kinase 2 aggravates the development of mild chronic dextran sulfate sodium colitis independently of expression of intestinal cytokines TNFα, TGFB1, and IL-6
por: Kersting S, et al.
Publicado: (2013) -
Deletion of PPAR-γ in immune cells enhances susceptibility to antiglomerular basement membrane disease
por: Cristen Chafin, et al.
Publicado: (2010)